Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Pentixapharm AG logo — improves the life of patients with malignant diseases throug...

Pentixapharm AG

improves the life of patients with malignant diseases through targeted molecular diagnostic and therapy

Founded 2019 Germany Berlin, Germany 33 employees Series A Total: $15.00M Biotechnology, Health Care +2

General Information

Company Name Pentixapharm AG
Founded Year 2019
Location Germany Berlin, Germany
Employees 33
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Series A
Business Model B2B, B2B2C
Revenue Model Product Sales, Licensing
Offices as of Sep 2026
Berlin, Germany Wurzburg, Germany
Social

BounceWatch is an independent company data service, not affiliated with Pentixapharm AG. To contact Pentixapharm AG, visit pentixapharm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pentixapharm AG compare?

A PDF of Pentixapharm AG and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pentixapharm AG soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pentixapharm AG

Pentixapharm AG is a biotechnology company founded in 2019 and headquartered in Germany. The company is committed to enhancing the lives of patients with malignant diseases by delivering targeted molecular diagnostics and therapies, encapsulated in its slogan: "improves the life of patients with malignant diseases through targeted molecular diagnostic and therapy".

Operating within the Biotechnology, Health Care, Life Sciences, and Pharmaceutical sectors, Pentixapharm AG represents a promising proposition in the rapidly evolving life sciences industry. Their focus on precision medicine underscores its potential for growth and impact in a market increasingly geared towards personalized healthcare solutions.

The company's most recent financial achievement was a €15.00M Series A investment received on 01 February 2020 from the ELSA Eckert Life Science Accelerator. This investment underscores the confidence placed in Pentixapharm AG by notable industry investors, poised to support its advancement in therapeutic and diagnostic innovations.

Business keywords: Theranostic Radiopharmaceuticals, Molecular Diagnostics, Oncology, Radiopharmaceutical Development, CXCR4-receptor Targeting, CNS Lymphoma, Phase II Trials, Phase I Trials, Cancer Therapy, Targeted Therapy, Radiopharmaceutical Pair, Proof-of-Concept Studies

Services & Products

Development of first-in-class radiopharmaceutical compounds
Phase-III clinical trial management
Advanced PET-Diagnostics for medical conditions

Target Customers

Medical Institutions Healthcare Professionals Patients with Hemato-Oncological Conditions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €15.00M 1
ELSA Eckert Life Science Accelerator
ELSA Eckert Life Science Accelerator
01 Feb 2020
Corporate Spinout Undisclosed 1
Eckert & Ziegler Bebig SA
01 Jun 2019

Pentixapharm AG Alternatives & Competitors

View All Alternatives
Pentixapharm AG vs
RayzeBio
RayzeBio United States

Targeted innovative radiopharmaceuticals for cancer

Acquired
258 employees
Biotechnology, Health Care
Compare Pentixapharm AG vs RayzeBio
Pentixapharm AG vs
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. United States

Targeted α-Particle Radiotherapy for Cancer

Grant
10 employees
Biotechnology, Health Care
Compare Pentixapharm AG vs Viewpoint Molecular Targeting, Inc.
Pentixapharm AG vs
CatalYm GmbH
CatalYm GmbH Germany

Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immu...

Series D
56 employees
Biotechnology, Health Care
Also compare with: Pentixapharm AG vs ImaginAb ImaginAb View all alternatives

FAQ About Pentixapharm AG

improves the life of patients with malignant diseases through targeted molecular diagnostic and therapy
Pentixapharm AG was founded in 2019.
Pentixapharm AG is headquartered in Berlin, Germany. As of Sep 2026, it also has offices in Wurzburg, Germany.
Pentixapharm AG operates in Biotechnology, Health Care, Life Sciences and Pharmaceutical. Its work centres on Theranostic Radiopharmaceuticals, Molecular Diagnostics, Oncology and Radiopharmaceutical Development. Its customers include Medical Institutions, Healthcare Professionals and Patients with Hemato-Oncological Conditions.
Pentixapharm AG has a B2B and B2B2C business model. Its revenue comes from Product Sales and Licensing.
Pentixapharm AG has approximately 33 employees.
Pentixapharm AG has completed 2 funding rounds, raising a total of $15.00M. The latest funding stage is Series A.
Pentixapharm AG offers: Development of first-in-class radiopharmaceutical compounds, Phase-III clinical trial management, Advanced PET-Diagnostics for medical conditions.
Top alternatives and competitors to Pentixapharm AG include RayzeBio, Viewpoint Molecular Targeting, Inc., CatalYm GmbH, Avenzo Therapeutics, BeyondSpring. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pentixapharm AG and RayzeBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pentixapharm AG, https://bouncewatch.com/company/pentixapharm, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes